Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials

European Heart Journal

28 February 2024
Organised by: Logo
ESC Journals PREVENTIVE CARDIOLOGY Risk Factors and Prevention

ESC 365 is supported by